ADP
58
-4
VRSN
48
-5
AMG
38
2
AMT
41
-4
CAG
47
3
PAYX
47
-7
WHR
36
-10
NOC
47
-6
APD
32
3
HON
53
-4
NEM
61
-2
T
41
2
ROK
46
3
ILMN
38
2
HES
79
2
KR
64
8
URBN
70
7
UA
33
3
OKE
71
-3
IPG
53
3
ADP
58
-4
VRSN
48
-5
AMG
38
2
AMT
41
-4
CAG
47
3
PAYX
47
-7
WHR
36
-10
NOC
47
-6
APD
32
3
HON
53
-4
NEM
61
-2
T
41
2
ROK
46
3
ILMN
38
2
HES
79
2
KR
64
8
URBN
70
7
UA
33
3
OKE
71
-3
IPG
53
3
Financhill
Back

ASLAN Pharmaceuticals 10K Form

Sell
16

ASLN
ASLAN Pharmaceuticals

Last Price:
0.44
Seasonality Move:
-19.01%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive ASLN News And Ratings

See the #1 stock for the next 7 days that we like better than ASLN

ASLN Financial Statistics

Sales & Book Value

Annual Sales: $12M
Cash Flow: $0
Price / Cash Flow: 0
Annual Sales: $-0.76
Price / Book: 0

Profitability

EPS (TTM): -2.61470
Net Income (TTM): $-44.22M
Gross Margin: $12M
Return on Equity: 0%
Return on Assets: 0%

ASLAN Pharmaceuticals Earnings Forecast

Key ASLAN Pharmaceuticals Financial Ratios

  • The Gross Profit Margin over the past 9 years for ASLN is 100.00%.
  • The Selling, General & Administrative Expenses for ASLN have been equal to 110.34% of Gross Profit Margin.
  • The Research & Development expenses have been 354.13% of Revenue.
  • The Interest Expense is -9.78% of Operating Income.
  • The Net Earning history of ASLN is -368.50% of Total Revenues.
  • Per Share Earnings over the last 10 years have been positive in 5 years.

ASLAN Pharmaceuticals Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: ASLN
CUSIP: 04522R
Website: aslanpharma.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

ASLN Technical Analysis vs Fundamental Analysis

Sell
16
ASLAN Pharmaceuticals (ASLN) is a Sell

Is ASLAN Pharmaceuticals a Buy or a Sell?